341 related articles for article (PubMed ID: 32453074)
1. Atrial Fibrillation in COVID-19: From Epidemiological Association to Pharmacological Implications.
Russo V; Rago A; Carbone A; Bottino R; Ammendola E; Della Cioppa N; Galante D; Golino P; Nigro G
J Cardiovasc Pharmacol; 2020 Aug; 76(2):138-145. PubMed ID: 32453074
[TBL] [Abstract][Full Text] [Related]
2. Guidance on Short-Term Management of Atrial Fibrillation in Coronavirus Disease 2019.
Rattanawong P; Shen W; El Masry H; Sorajja D; Srivathsan K; Valverde A; Scott LR
J Am Heart Assoc; 2020 Jul; 9(14):e017529. PubMed ID: 32515253
[TBL] [Abstract][Full Text] [Related]
3. Management of Atrial Fibrillation in COVID-19 Pandemic.
Hu YF; Cheng WH; Hung Y; Lin WY; Chao TF; Liao JN; Lin YJ; Lin WS; Chen YJ; Chen SA
Circ J; 2020 Sep; 84(10):1679-1685. PubMed ID: 32908073
[TBL] [Abstract][Full Text] [Related]
4. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
Bifulco M; Gazzerro P
Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
[No Abstract] [Full Text] [Related]
5. Is the type of diabetes treatment relevant to outcome of COVID-19?
Bloomgarden Z
J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
[No Abstract] [Full Text] [Related]
6. COVID-19 update: Covid-19-associated coagulopathy.
Becker RC
J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
[No Abstract] [Full Text] [Related]
7. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.
Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B
Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439
[No Abstract] [Full Text] [Related]
8. Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection.
Nauka PC; Oran E; Chekuri S
Thromb Res; 2020 Aug; 192():27-28. PubMed ID: 32419710
[TBL] [Abstract][Full Text] [Related]
9. Sofosbuvir for COVID-19 infection: A potential candidate.
Gupta R; Dhamija P
Indian J Pharmacol; 2020; 52(3):232-233. PubMed ID: 32874010
[No Abstract] [Full Text] [Related]
10. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response.
Ryan PM; Caplice N
Open Heart; 2020 Jun; 7(1):. PubMed ID: 32532804
[No Abstract] [Full Text] [Related]
11. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
Rani S; Grover S; Mehra A; Sahoo S
Indian J Pharmacol; 2020; 52(3):229-231. PubMed ID: 32874009
[No Abstract] [Full Text] [Related]
13. Covid-19 treatment update: follow the scientific evidence.
Becker RC
J Thromb Thrombolysis; 2020 Jul; 50(1):43-53. PubMed ID: 32338320
[No Abstract] [Full Text] [Related]
14. Coronavirus disease 2019 infection and the cardiovascular system.
Romeo F; Calcaterra G; Barilla F; Mehta JL
J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):403-405. PubMed ID: 32324641
[No Abstract] [Full Text] [Related]
15. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.
Greco A; Buccheri S; D'Arrigo P; Calderone D; Agnello F; Monte M; Milluzzo RP; Franchina AG; Ingala S; Capodanno D
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):335-337. PubMed ID: 32671399
[No Abstract] [Full Text] [Related]
17. Statin therapy and SAR-COV-2: an available and potential therapy?
Abdel-Latif RG; Mohammed S; Elgendy IY
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
[No Abstract] [Full Text] [Related]
18. Neuraxial Procedures in COVID-19-Positive Parturients: A Review of Current Reports.
Bauer ME; Chiware R; Pancaro C
Anesth Analg; 2020 Jul; 131(1):e22-e24. PubMed ID: 32221171
[No Abstract] [Full Text] [Related]
19. Social media in the era of COVID-19.
Aggarwal NR; Alasnag M; Mamas MA
Open Heart; 2020 Sep; 7(2):. PubMed ID: 32994354
[No Abstract] [Full Text] [Related]
20. Treatments for COVID-19: emerging drugs against the coronavirus.
Potì F; Pozzoli C; Adami M; Poli E; Costa LG
Acta Biomed; 2020 May; 91(2):118-136. PubMed ID: 32420936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
